HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?

AuthorsCristina Gervasoni, Agostino Riva, Caterina Impagnatiello, Massimo Galli, Dario Cattaneo
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 57 Issue 3 Pg. 480-1 (Aug 2013) ISSN: 1537-6591 [Electronic] United States
PMID23616494 (Publication Type: Letter)
Chemical References
  • Anti-HIV Agents
  • Antitubercular Agents
  • Pyrrolidinones
  • Raltegravir Potassium
  • Rifampin
Topics
  • Administration, Oral
  • Anti-HIV Agents (administration & dosage, pharmacokinetics)
  • Antitubercular Agents (administration & dosage, pharmacokinetics)
  • Coinfection (drug therapy)
  • Drug Interactions
  • HIV Infections (complications, drug therapy)
  • Humans
  • Pyrrolidinones (administration & dosage, pharmacokinetics)
  • Raltegravir Potassium
  • Rifampin (administration & dosage, pharmacokinetics)
  • Tuberculosis (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: